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Objective: This paper reports the frequency, type, and degree of dyslipidemia in obese children 
before therapeutic intervention. The relationships between lipid values and weight status, as 
well as lipid values and physical ﬁ  tness, of these children were also investigated.
Design and methods: The initial examination of the Freiburg Intervention Trial for Obese 
Children (FITOC) measured the values of triglycerides (TG), total cholesterol (C), low-density 
lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) in 546 
obese children aged 7–12 (body mass index [BMI]   97th percentile), and compared these 
values with those of the age- and sex-speciﬁ  c reference group in the Lipid Research Clinics 
Population Studies Data Book (LRC). Four groups were selected according to the follow-
ing scheme: A, Normolipidemia; B, Hyper-LDL-cholesterolemia alone; C, Hypo-HDL-C + 
hypertriglyceridemia; D, Combined hyperlipidemia = Hyper-LDL-C + hypertriglyceridemia. 
Body mass index, BMI-SDS (corrected BMI), and physical performance in watt/kg body weight 
were measured.
Results: A total of 45.8% of the overweight children showed an abnormal lipid proﬁ  le. Ten 
percent of the children had high LDL-C levels (group B), while 15% had increased LDL-C 
and increased TG (group D) (higher prevalence in boys). In 18.9% we found increased TG, 
combined with decreased HDL-C values (group C).
Conclusion: Obese children are at risk of dyslipoproteinemia and related diseases. Children 
with the highest BMI-SDS and lowest physical ﬁ  tness have the lowest HDL-C values and 
increased TG, indicating a higher risk for the metabolic syndrome.
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Introduction
Obesity is categorized as a global epidemic by the World Health Organisation (WHO). 
The National Health and Nutrition Examination Survey (NHANES) (1999–2000) stated 
that nearly 65% of American adults were overweight (BMI   25 kg/m2). The prevalence 
of obesity had increased from 23% to 31% since the previous NHANES III Survey 
(1988–1994). This development can also be observed in children and adolescents 
(Troiano et al 1995; Flegal et al 1998; Ogden et al 2002, 2003). Among children 6–15 
years old, the prevalence of obesity increased 7% (overweight 3.5%) between 1996 and 
2001 according to an English Health Survey (Joint Health Surveys Unit 2002). Cases 
of extreme obesity are increasingly observed in Germany and other European countries 
(Kromeyer-Hauschild et al 1999; Kalies et al 2002; Frye and Heinrich 2003; Ogden 
et al 2003). This development is alarming and predisposes this particular population 
to metabolic and orthopedic risk factors, as well as psychosocial disorders.
Interest in the pathogenesis of childhood atherosclerosis has intensiﬁ  ed in the past 
few decades (Berenson et al 1998; Freedman et al 1999; Frontini et al 2003; Kalies 
et al 2002; Kromeyer-Hauschild et al 1999; Srinivasan et al 2003). The Bogalusa Heart 
Study demonstrated that diseased adolescents with high levels of total cholesterol (C) Vascular Health and Risk Management 2008:4(5) 1090
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and low-density lipoprotein (LDL-C) levels already had 
atherosclerotic plaques (Tracy et al 1995). This constellation 
is caused by excessive food consumption and a decrease 
in physical activity (Berg et al 1994; Berg and Korsten-
Reck 1995). An important risk factor for the development 
of atherosclerotic coronary heart disease is the metabolic 
syndrome characterized by insulin resistance, obesity, high 
blood pressure, and dyslipidemia (Steinberger 2003). Early 
childhood obesity probably plays an important role in the 
development of this metabolic syndrome.
The Freiburg Intervention Trial for Obese Children 
(FITOC) aims to reduce obesity through physical activity, 
diet, and behavioral education (Korsten-Reck et al 2005). 
This paper reports the status of frequency, type, and degree 
of dyslipidemia in obese children before therapeutic interven-
tion. In addition the relationships between lipid values and 
weight status as well as lipid values and physical ﬁ  tness of 
these children were investigated.
Methods
Patients
At initial examination, the children of the study 
were 7 to 12 years old (mean: 10.11 ± 1.25 years). Chil-
dren participating in the program (body mass index [BMI] 
above the 97th percentile of the German reference group) 
(Kromeyer-Hauschild et al 2001) were referred by family 
doctors, pediatricians, or school doctors. Some were outpa-
tients at two university clinics (Universitäts-Kinderklinik, 
Kinder- und Jugendpsychiatrie der Universitätsklinik). The 
content of the FITOC intervention program has been described 
previously (Korsten-Reck et al 2005). We summarize the 
lipid proﬁ  le values of the pre-start examination of all partici-
pants taken over 9 years. We compared the values of these 
children (n = 546) with the age- and sex-speciﬁ  c reference 
group of the Lipid Research Clinics Population Studies Data 
Book (LRC). These LRC data are given in Table 1 (US Dept 
of  Health and Human Services 1980). No guideline values for 
childhood lipid values appear in German publications. The 
age- and sex-speciﬁ  c 90th percentile (P90) for triglycerides 
(TG) as well as for LDL-cholesterol values was set as the 
upper limit and the age- and sex-speciﬁ  c 10th percentile (P10) 
for high-density lipoprotein cholesterol (HDL-C) was deﬁ  ned 
as the lower limit. Four groups were selected according to 
the following scheme: A, Normolipidemia [triglycerides 
(TG)   age- and sex-speciﬁ  c P90, HDH-C (HDL-C)   age- 
and sex-specific P10]; B: Hyper-LDL-cholesterolemia 
alone [LDL-C   age- and sex-speciﬁ  c P90, TG   age- and 
sex-speciﬁ  c P90]; C: Hypo-HDL-C + Hypertriglyceridemia 
[HDL-C   age- and sex-specific P10, TG   age- and 
sex-speciﬁ  c P90]; D: Combined hyperlipidemia = Hyper-LDL-
C + Hypertriglyceridemia [LDL-C   age- and sex-speciﬁ  c 
P90, TG   age- and sex-speciﬁ  c P90]. As well as total choles-
terol, TG, HDL-C, and LDL-C, BMI, BMI-standard devia-
tion score-values (BMI-SDS) (corrected BMI), and physical 
performance in watt/kg body weight were measured.
Methods
The biochemical methods were identical during the whole 
investigation. Total cholesterol was assayed using enzymatic 
colorimetric tests (cholesterol CHOD-PAP-method); 
LDL-cholesterol and HDL-cholesterol were measured using 
lipoprotein electrophoresis (Helena REP Diagnostic, Greiner 
Bio Chemica). Our laboratory takes part in an external 
certiﬁ  cation program (DIN EN ISO 9001).
BMI was used as a basis for weight status. To correct 
for age and sex, individual BMI-values were converted to 
Z-scores (SDS values). Calculation of SDS values was based 
on the national reference data available for German children 
(Kromeyer-Hauschild et al 2001). These references were 
derived using Cole’s LMS method (Cole and Green 1992), 
which allows BMI in individual subjects to convert to SD 
scores as follows:
SDS = [(X/M(t))L(t) -1]/L(t)S(t)
where X = individual BMI-value, L = Box-Cox power, 
M = Median, and S = coefﬁ  cient of variation for individual 
age (t) and sex from the reference group. Results are indicated 
as BMI-SDS values.
Physical performance as watt/kg bodyweight was gauged 
with a standard bicycle ergometer (Lode, Groningen, NL) 
using a typical test protocol starting at 25 or 50 watts and 
increasing the work load by 25 watts every three minutes 
until exhaustion.
The sex-specific number of children in the above 
mentioned age- and sex-speciﬁ  c 90th percentiles for TG 
and LDL as well below the 10th percentile for HDL of the 
Table 1 LRC-data for LDL- and HDL-cholesterol, and triglycerides 
90th percentile by age, gender, and race
White boys White girls
Age 5–9 10–14 5–9 10–14
LDL-cholesterol 117 122 125 126
HDL-cholesterol 42 40 38 40
Triglycerides 85 102 90 114
Abbreviations: LDL, low-density lipoprotein, 90th percentile; LRC,   The Lipid 
Research Clinics’ Population Studies Data Book, Volume 1;   Triglycerides, 90th 
percentile; HDL, high-density lipoprotein, 10th percentile.Vascular Health and Risk Management 2008:4(5) 1091
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reference group was calculated. The children were also 
classiﬁ  ed in the above mentioned lipid groups. Gender 
differences between the frequencies in the four lipid groups 
were tested by using chi-square test for categorical variables. 
Analyses of variance (ANOVA) with Tamhane T2 post hoc 
contrasts were used to compare the differences in BMI-SDS 
and ﬁ  tness (watt/kg bodyweight) between the lipid-groups. 
Normal distribution of BMI-SDS (p = 0.945) and watt/kg 
bodyweight (p = 0.184) were examined by Kolmogorov-
Smirnoff test. Statistical inferences were drawn at a signiﬁ  -
cance level of 5%. All statistical analyses were performed 
using SPSS 11.5.2.1 (SPSS Inc., Chicago, IL). The study was 
approved by the University of Freiburg Ethics Committee.
Results
The characteristics of the patients in this study are summa-
rized in Table 2. The BMI and BMI-SDS of the boys were 
signiﬁ  cantly higher than those of the girls.
About 40% of the children have total cholesterol values 
above the age- and sex-speciﬁ  c 90th percentile, and about 
30% above the 90th percentile for LDL-C and TG (Table 3). 
In contrast more than 20% of the children showed a HDL-C 
value below the age- and sex-speciﬁ  c 10th percentile. There 
are more boys with LDL-C values above the 90th percentile 
than girls (Table 3). In both sexes, a higher degree of lipid 
abnormalities was found in our overweight children com-
pared with the LRC data (Figure 1). A large number of 
children also have combined lipid disturbances. Only half the 
children showed a normal lipid proﬁ  le (group A). We found 
signiﬁ  cant sex differences among the four groups (Table 4). 
About 12% of the children had only high LDL-C level 
(group B), while 15% had increased LDL-C and increased 
TG (higher prevalence in boys) (group D) (Table 4). In 18.9% 
we found increased TG combined with decreased HDL-C 
values (group C). This combination was more common in 
girls (23% versus 14%).
There is a signiﬁ  cant variation in BMI-SDS and physical 
ﬁ  tness between the four lipid groups (Tables 5 and 6). 
Children with the highest BMI-SDS and the lowest physical 
fitness have the lowest HDL-C values and highest TG 
(group C) indicating a higher risk for metabolic syndrome. 
Group B shows no signiﬁ  cant differences in the level of 
BMI-SDS and physical ﬁ  tness compared with group A.
Discussion
The purpose of this study was to show the lipid values of a 
cohort of obese children ( 97th percentile) before starting 
an intervention program. Obesity in childhood predisposes 
for metabolic syndrome with high blood pressure, changes 
in glucose metabolism, and dyslipidemia in adulthood 
(Hubert et al 1983; Kaufman 2002; McGill et al 2002; 
Kavey et al 2003). The relationship of obesity to cardiovas-
cular risk factors is not only deﬁ  ned by the level of obesity 
but also by the distribution of fat. Research has shown 
Table 2 Characteristics of the obese children examined
N Mean SD
Age (yrs) Boys 249 10.120 1.241
Girls 297 10.104 1.255
Total 546 10.112 1.247
BMI (kg/m2) Boys 249 27.1# 3.6
Girls 297 26.2# 3.4
Total 546 26.6 3.5
BMI-SDS Boys 249 2.37* 0.45
Girls 297 2.26* 0.49
Total 546 2.31 0.47
WATT/KG Boys 178 1.9 0.5
Girls 214 1.8 0.4
Total 392 1.8 0.4
Notes: Signiﬁ  cant differences between sexes; #p = 0.001; U-Test *p = 0.005;   T-Test.
Abbrevations: BMI, body mass index; BMI-SDS, body mass index standard deviation 
score-values.
Table 3 Frequencies (%) of children with values for CH, LDL-C, and TG above P90 and for HDL-C below P10
Number 
of children
Boys Girls Total
(boys/girls) n % (95%CI) n % (95% CI) n (%) (95% CI)
CH   P90 546 (249/297) 102 41.0 (34.8–47.4) 108 36.4 (30.9–42.1) 210 38.5 (34.4–42.7)
LDL-C   P90 541 (248/293) 80 32.3 (26.5–38.5) 67 22.9 18.2–28.1) 147 27.2 (23.5–31.1)
TG   P90 545 (248/297) 82 33.1 (27.2–39.3) 103 34.7 (29.3–40.4) 185 33.9 (30.0–38.1)
HDL-C   P10 545 (249/296) 50 20.1 (15.3–25.6) 74 25.0 (20.1–30.3) 124 22.8 (19.3–26.5)
Note: 95% CI, 95% exact conﬁ  dence limits.
Abbreviations: CI, conﬁ  dence interval; CH, cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; P10, 10th percentile; P90, 
90th percentile;   TG, triglycerides.Vascular Health and Risk Management 2008:4(5) 1092
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that children with a large visceral component compared 
to peripheral fat can develop metabolic syndrome just 
like adults (Moreno et al 2002). Obese children develop 
not only insulin resistance but dyslipidemia as result of 
obesity and the prevalence is higher than seen among 
normal weight children (Freedman et al 1999). One study 
by Berenson demonstrates that obesity is not only associ-
ated with dyslipidemia but accelerates the atherosclerotic 
process in adolescents and young adults (Berenson et al 
1998). Recently published pediatric studies have focused 
on atherosclerosis as a process beginning in early childhood 
and related to obesity. Framingham Study data showed 
an increased incidence of cardiovascular events with 
increasing bodyweight, independent of gender.
Considering these results, lipid value screening appears 
to be helpful at the beginning of an intervention program for 
obese children. However, medical treatment of dyslipidemia 
in childhood is controversial and is so far only indicated for 
familial heterozygotic hypercholesterolemia (Stefanutti et al 
1999; Stein et al 1999). In contrast to treatment with drugs, 
lifestyle intervention has no inherent risk.
We compared pre-start FITOC lipid data from obese 
children with the LRC data because there are only a few 
comparable studies in the literature. Although the LRC 
data were collected in 1980, the 1998 American Academy 
of Pediatrics (AAP) recommendations set the same limits 
for LDL-C. These recommendations define lower than 
110 mg/dL as a normal value, 130 mg/dL as borderline high, 
and more than 130 mg/dl as a high value (AAP 1998).
Comparing the distribution of the lipid values of 
FITOC children with levels in the LRC studies, only 
54.2% of the FITOC children showed a normal lipid 
proﬁ  le (group A), whereas about 10% had a hyper-LDL-C 
alone (group B) and about 20% showed the “atherogenic” 
lipid proﬁ  le with hypo-HDL-C and hyper-trigliceridemia 
(group C) (Steinberger 2003).
Our results conﬁ  rm the ﬁ  ndings of other studies which 
show a higher frequency of dyslipidemia in obese children 
(Freedman et al 1999; Dirisamer and Widhalm 2002).
The Bogalusa Heart Study reported the probability of 
overweight children developing high TG, and total- and 
LDL-C levels 2.4–7.1 times greater than in normal-weight 
children. The increase in individual insulin resistance may 
explain a signiﬁ  cant part of the variance in the TG, LDL-C, 
and HDL-C values (Freedman et al 1999). In Germany 
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Figure 1 Distribution of the individual LDL-C of FITOC Children compared with 
the LRC Study.
Abbreviations: FITOC, freiburg intervention trial for obese children; LDL-C, 
low-density lipoprotein cholesterol; LRC, lipid research clinics population studies 
data book.
Table 4 Distribution of the children in the four lipid proﬁ  le groups
Group Boys Girls Total
n % (95%CI) n % (95%CI) n % (95%CI)
A Normolipidemia 
(HDL   P10 + TG   P90)
134 53.8 (47.4–60.1) 162 54.5 (48.7–60.3) 296 54.2 (49.9–58.5)
B Hyper-LDL-C alone 
(LDL   P90 + TG   P90)
32 12.9 (9.0–17.7) 32 10.8 (7.5–14.9) 64 11.7 (9.2–14.7)
C Hypo-HDL-C + Hypertriglyceridemia 
(HDL   P10 + TG   P90)
35 14.1 (10.0–19.0) 68 22.9 (18.2–28.1) 103 18.9 (15.7–22.4)
D Hyper-LDL-C + Hypertriglyceridemia 
(LDL   P90 + TG   P90)
48 19.3 (14.6–24.7) 35 11.8 (8.4–16.0) 83 15.2 (12.3–18.5)
Notes: 95% CI, 95% exact conﬁ  dence limits.
Abbreviations: CI, conﬁ  dence interval; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; P10, 10th percentile; P90, 90th percentile; 
TG, triglyceride.Vascular Health and Risk Management 2008:4(5) 1093
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we have few representative population-based samples of 
childhood lipid values and cardiovascular risk factors. 
One other study presents cardiovascular risk factors of a 
large population, but combined-lipid-cluster-groups and 
correlations to physical-performance data as in our study are 
not mentioned (Reinehr 2005). Moreover, we found signiﬁ  -
cantly higher total-C and LDL-C values in boys as well as 
TG in our total cohort compared with an Austrian control 
group (Dirisamer and Widhalm 2002).
The mechanism of change in the lipid proﬁ  le could be: 
hyperinsulinemia causes hepatic VLDL-synthesis and leads 
to increased TG- and LDL-C-levels. The lack of the effect of 
insulin on lipoproteinlipase in peripheral tissues could then 
result in an increase in TG and LDL-C.
In addition, hyperinsulinemia in children leads to further 
alterations in fatty acid oxidation and concentrations (Sinaiko 
et al 2002). Other metabolic factors, such as an increase in 
levels of apolipoprotein B, homocysteine, and C-reactive 
protein are risk factors for atherosclerotic coronary heart 
disease (Sinha et al 2002; Halle et al 2004).
There is no doubt that the atherosclerotic process in adults 
seems to originate in childhood obesity with dyslipidemia, 
and must be treated in a timely fashion. In this age group, 
nondrug therapy is possible because unhealthy eating and 
behavioral habits are not yet fully established. New eating, 
behavioral, and activity patterns can be formed (Epstein 
et al 2000).
In conclusion, obesity in childhood predisposes for 
coronary heart disease in adults. In view of the socio-
economic significance of the increasing prevalence of 
childhood obesity, early screening is indispensable. Particular 
attention should be focused on the timely prevention 
of childhood obesity and corresponding dyslipidemia. 
Risk groups should be identiﬁ  ed and treated accordingly. 
Longitudinal data of dyslipidemia in obese children are 
important for the prevention of metabolic syndrome.
Table 5 Mean BMI-SDS-values in the different lipid proﬁ  le groups
Group* Boys Girls Total
n Mean SD n Mean SD n Mean SD
A1,2 Normolipidemia 
(HDL   P10 + TG   P90)
134 2.3 0.4 162 2.1 0.5 296 2.2 0.4
B3 Hyper-LDL-C alone 
(LDL   P90 + TG   P90)
32 2.4 0.6 32 2.1 0.5 64 2.3 0.5
C1,3 Hypo-HDL-C + Hypertriglyceridemia 
(HDL   P10 + TG  P90)
35 2.5 0.5 68 2.5 0.5 103 2.5 0.5
D2 Hyper-LDL-C + Hypertrigliceridemia 
(LDL   P90 + TG   P90)
48 2.4 0.4 35 2.3 0.4 83 2.4 0.4
Notes: *Signiﬁ  cant differences between the groups (ANOVA; p   0.001); 1Signiﬁ  cant differences between group A and C (Tamhane T2; p   0.05); 2Signiﬁ  cant differences 
between group A and D (Tamhane T2; p   0.05); 3Signiﬁ  cant differences between group B and C (Tamhane T2; p   0.05).
Abbreviations: BMI-SDS, MI-SDS, body mass index standard deviation score-values; CI, conﬁ  dence interval; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density 
lipoprotein-cholesterol; P10, 10th percentile; P90, 90th percentile;   TG, triglycerides.
Table 6 Mean physical ﬁ  tness in the different lipid proﬁ  le groups
Group* Boys Girls Total
n Mean SD n Mean SD n Mean SD
A1 Normolipidemia 
(HDL   P10 + TG   P90)
104 1.9 0.5 114 1.8 0.4 218 1.9 0.4
B3 Hyper-LDL-C alone 
(LDL   P90 + TG   P90)
16 2.0 0.4 25 1.9 0.4 41 1.9 0.4
C1,3 Hypo-HDL-C + Hypertriglyceridemia 
(HDL   P10 + TG   P90)
25 1.7 0.5 50 1.7 0.3 75 1.7 0.4
D Hyper-LDL-C + Hypertriglyceridemia 
(LDL   P90 + TG   P90)
33 1.8 0.4 25 1.8 0.4 58 1.8 0.4
Notes: *Signiﬁ  cant differences between the groups (ANOVA; p = 0.001); 1Signiﬁ  cant differences between group A and C (Tamhane T2; p   0.05); 3Signiﬁ  cant differences 
between group B and C (Tamhane T2; p   0.05).
Abbreviations: HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; P10, 10th percentile; P90, 90th percentile; SD, standard deviation; TG, 
triglycerides.Vascular Health and Risk Management 2008:4(5) 1094
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